SGMT: Sagimet Biosciences Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 124.54
Enterprise Value ($M) 47.53
Book Value ($M) 170.68
Book Value / Share 5.56
Price / Book 0.73
NCAV ($M) 153.10
NCAV / Share 4.99
Price / NCAV 0.81

Profitability (mra)
Return on Invested Capital (ROIC) -0.22
Return on Assets (ROA) -0.39
Return on Equity (ROE) -0.41

Liquidity (mrq)
Quick Ratio 38.41
Current Ratio 38.41

Balance Sheet (mrq) ($M)
Current Assets 157.19
Assets 174.78
Liabilities 4.09
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
11-14 13G/A Point72 Asset Management, L.P. 8.00 53.05
11-14 13G/A Baker Bros. Advisors Lp 4.99 5.63
11-14 13G/A Hillhouse Capital Management, Ltd. 2.40 -50.00
11-14 13G Blue Owl Capital Holdings LP 5.46
03-11 13G/A Fmr Llc 2.44 -61.38
02-14 13G Kpcb Pandemic & Bio Defense Fund Llc 6.30
02-14 13G New Enterprise Associates 13 Lp 6.60

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-03-25 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-01-31 578,055 1,371,714 42.14
2025-01-30 183,436 573,434 31.99
2025-01-29 359,468 933,821 38.49
2025-01-28 499,437 1,206,366 41.40
2025-01-27 743,005 2,410,812 30.82

(click for more detail)

Similar Companies
RYTM – Rhythm Pharmaceuticals, Inc. SAGE – Sage Therapeutics, Inc.
SCYX – SCYNEXIS, Inc. SIGA – SIGA Technologies, Inc.
SKYE – Skye Bioscience, Inc.


Financial data and stock pages provided by
Fintel.io